Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood clotting treatments for COVID-19

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to Director's Page - Statements, Articles, and Media for National Institutes of Health (NIH).

 


A new item has been added to the Director's Page - Statements, Articles, and Media: